Todd Watanabe
Amministratore Delegato presso ARCUTIS BIOTHERAPEUTICS, INC.
Patrimonio netto: 9 M $ in data 30/04/2024
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Keith Leonard | M | 62 | 14 anni | |
Bhaskar Chaudhuri | M | 69 | 8 anni | |
Patrick Heron | M | 53 | 8 anni | |
Jay Ramsinghani | M | - | 6 anni | |
Ciara Kennedy | M | 52 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 3 anni |
Neha Krishnamohan | F | 37 | 2 anni | |
Masaru Matsuda | M | 53 | 2 anni | |
Sue-Jean Lin | F | 65 | 3 anni | |
Terrie Curran | F | 55 | 4 anni | |
Ayisha Jeter | F | - | 4 anni | |
Howard Welgus | M | 72 | 8 anni | |
Volker Schellenberger | M | - |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 18 anni |
Ambrose Bailey | M | 60 | 9 anni | |
Halley Gilbert | F | 54 | 4 anni | |
Maria Hilado | F | 59 | 9 anni | |
Rajvir Madan | M | - | 3 anni | |
Tood Tucker | M | - | 4 anni | |
Jessica Robison | F | - | 5 anni | |
Mika Derynck | M | 61 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | - |
Amanda Sheldon | F | - | 3 anni | |
Bruce Binkowitz | M | - | 3 anni | |
Charlotte Merritt | F | 61 | 7 anni | |
Otello Stampacchia | M | 55 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | - |
Don Plummer | M | - | - | |
Meg Elias | F | 58 | 5 anni | |
David Berk | M | 45 | 5 anni | |
Maninder Hora | M | 70 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | - |
Patrick Burnett | M | 52 | 4 anni | |
Todd Edwards | M | 61 | 1 anni | |
Courtney Barton | F | 41 | 3 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Joseph Turner | M | 72 | 11 anni | |
Scott Burrows | M | 47 | 4 anni | |
John Smither | M | 71 | 13 anni | |
Nathaniel David | M | 56 | 11 anni | |
F. Ball | M | 68 | 2 anni | |
Angie You | M | 51 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 4 anni |
Daniel J. Estes | M | 43 | 3 anni | |
Frank Pompilio | M | 60 | 2 anni | |
François Kress | M | 57 | 5 anni | |
David W. Osborne | M | 62 | - | |
Keith L. Klein | M | 60 | 2 anni | |
Ricky Sun | M | 50 | - | |
Patricia A. Turney | F | 57 | - | |
Alexander G. Asam | M | 58 | 1 anni | |
Camille Samuels | F | 52 | 10 anni | |
Rowe Heather Armstrong | F | - | 1 anni | |
Jonathan Silverstein | M | 57 | 3 anni | |
David Schnell | M | 64 | 8 anni | |
Dennis Fenton | M | 72 | 9 anni | |
Hollings Renton | M | 77 | 1 anni | |
Robert Nelsen | M | 60 | 8 anni | |
Kenneth Lock | M | 50 | 3 anni | |
Jen Herbach | F | - |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 3 anni |
Kimberly Lathroum | F | - | 3 anni | |
Corey Padovano | M | - | - | |
Eric McIntyre | M | - | - | |
Lynn Navale | F | 53 | - | |
Ursula McCurry | F | - |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 2 anni |
Matthew Moore | M | 51 | 3 anni | |
Steven Pfeiffer | M | 48 | 4 anni | |
Alexander Azoy | M | 48 | - | |
Susan Lundeen Smuck | F | 57 | 9 anni | |
Bryan Irving | M | 60 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 3 anni |
Diane Stroehmann | F | 46 | 2 anni | |
Majed Kheir | M | 46 | 3 anni | |
Elisabeth Sandoval | F | 62 | 3 anni | |
Susan R. Lundeen-Smuck | F | 58 | 9 anni | |
Charles W. Stiefel | M | - | - | |
David Hirsch | M | 53 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 2 anni |
Douglas A. Rich | M | 55 | - | |
Patricia Millican | F | 51 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 2 anni |
Patricia Walker | M | 64 | 8 anni | |
Zaneta Odrowaz | F | - |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 2 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 73 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Todd Watanabe
- Contatti personali